Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,821 | -2,486 | -3,129 | -352 | 1,468 |
| Depreciation Amortization | 885 | 458 | 260 | 191 | 152 |
| Accounts receivable | -549 | -247 | -736 | -478 | -396 |
| Accounts payable and accrued liabilities | 225 | 137 | 157 | 82 | -172 |
| Other Working Capital | 727 | 616 | 7 | -416 | -813 |
| Other Operating Activity | -329 | -1,184 | -4,215 | -5,019 | -5,265 |
| Operating Cash Flow | $-6,862 | $-2,705 | $-7,656 | $-5,993 | $-5,026 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -271 | -69 | -10 | -10 | -6 |
| Net Acquisitions | 100 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 509 | 509 | 1,535 | 1,130 | 590 |
| Other Investing Activity | 0 | 100 | -1,700 | -1,700 | -1,700 |
| Investing Cash Flow | $338 | $540 | $-175 | $-580 | $-1,117 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 1,719 | N/A |
| Debt Repayment | -92 | -40 | N/A | N/A | 0 |
| Common Stock Issued | 2,704 | 1,472 | 6,226 | 57 | 1,762 |
| Financing Cash Flow | $2,613 | $1,432 | $6,226 | $1,776 | $1,762 |
| Beginning Cash Position | 7,507 | 7,507 | 6,847 | 6,847 | 6,847 |
| End Cash Position | 3,595 | 6,773 | 7,507 | 4,316 | 4,790 |
| Net Cash Flow | $-3,912 | $-734 | $660 | $-2,531 | $-2,058 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,862 | -2,705 | -7,656 | -5,993 | -5,026 |
| Capital Expenditure | -277 | -69 | -10 | -10 | -6 |
| Free Cash Flow | -7,140 | -2,775 | -7,666 | -6,003 | -5,032 |